Sjogren's syndrome is a systemic autoimmune disorder characterized by symptoms of oral and ocular dryness and a chronic, progressive loss of salivary and lacrimal function. The exocrine involvement is the result of a focal, peri-ductal mononuclear cell infiltrate and the subsequent loss of secretory epithelial cells. The mechanisms of this autoimmune exocrinopathy are not understood fully. Many recent investigations have described alterations in a number of immune mediators within the salivary glands. These studies provide new insights into the immune regulation of normal salivary gland functions and the mechanisms of gland damage in Sjogren's syndrome.
References
1.
Adamson TC, Fox RI, Frisman DM, Howell FV (1983). Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies. J Immunol130:203-208.
2.
Alpert S., Kang H., Weissman I., Fox RI (1994). Expression of granzyme A in salivary gland biopsies from patients with primary Sjogren's syndrome. Arthritis Rheum37:1046-1054.
3.
Anderson LG, Cummings NA, Asofsky R., Hylton MB, Tarpley TM Jr, Tomasi TB Jr, et al. (1972). Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögren's syndrome. Am J Med53:456-463.
4.
Atkinson )C., Travis WD, Pillemer SR, Bermudez D., Wolff A., Fox PC ( 1990). Major salivary gland function in primary Sjogren's syndrome and its relationship to clinical features. J Rheumatol17:318-322.
5.
Atkinson JC, Royce LS, Wellner R., Pillemer SR, Bermudez D., Fox PC (1995). Anti-salivary antibodies in Sjogren's syndrome. J Oral Pathol Med24:206-212.
6.
Aziz KE McCluskey PJ, Montanaro A., Wakefield D. (1992). Vascular endothelium and lymphocyte adhesion molecules in minor salivary glands of patients with Sjögren's syndrome. J Clin Lab Immunol37:39-49.
7.
Bateman AC, Wright DH (1993). Epitheliotropism in high-grade lymphomas of mucosa-associated lymphoid tissue. Histopatllol23:409-415.
8.
Bodeutsch C., de Wilde PCM, Kater L., Hene RJ, van den Hoogen FHJ, van de Putte LBA, et al. (1992). Labial salivary gland biopsy in Sjogren's syndrome. Netherland J Med40:148-157.
9.
Bodeutsch C., de Wilde PCM, Kater L., van den Hoogen FH, Hene RJ van Houwelingen JC, et al. (1993). Monotypic plasma cells in labial salivary glands of patients with Sjogren's syndrome: prognosticator for systemic lymphoproliferative disease. J Clin Pathol46:123-128.
10.
Bunim JJ, Talal N. (1963). The association of malignant lymphoma with Sjogren's syndrome. Trans Assoc Am Phys76:45-56.
11.
Cattaneo R., Tosoni C., Franzini M., Manca N., Gelmi M., Turano A., et al. (1993). Antibodies to retroviral proteins in Sjogren's syndrome. Ann Rheum Dis52:621.
12.
Cauli A., Yanni G., Pitzalis C., Challacombe S., Panayi GS ( 1995) Cytokine and adhesion molecule expression in the minor salivary glands of patients with Sjogren's syndrome and chronic sialoadenitis. Ann Rheum Dis54:209-215.
13.
Daniels TE (1984). Labial salivary gland biopsy in Sjögren's syndrome: Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum27:147-156.
14.
Daniels TE (1996). Sjogren's syndrome: Clinical spectrum and current diagnostic controversies. Adv Dent Res10: 3-8.
15.
De Vita S., Ferraccioli G., de Re V., Dolcetti R., Carbone A., Bartoli E. (1994) The polymerase chain reaction detects B cell clonalities in patients with Sjogren's syndrome and suspected malignant lymphoma. J Rheumatol21:1497-1501.
16.
Deacon EM, Matthews JB, Potts AJC, Hamburger J., Mageed RA, jefferis R. (1991). Expression of rheumatoid factor associated cross-reactive idiotopes by glandular B cells in Sjogren's syndrome. Clin Exp Immunol83:280-285.
17.
Diss TC, Peng H., Wotherspoon AC, Pan L., Speight PM, Isaacson PG (1993). A single neoplastic clone in sequential biopsy specimens from a patient with primary gastric mucosa-associated lymphoid-tissue lymphoma and Sjogren's syndrome. N Engl J Med329:172-175.
18.
Diss TC, Wotherspoon AC, Speight PM, Pan L., Isaacson PG (1995). B-cell monoclonality, Epstein Barr virus and t(14;18) in myoepithelial sialadenitis and low-grade B-cell MALT lymphoma of the parotid gland. Am J Surg Pathol19:531-536.
19.
Edwards JC, Wilkinson LS, Speight P., Isenberg DA (1993). Vascular cell adhesion molecule 1 and alpha 4 and beta 1 integrins in lymphocyte aggregates in Sjogren's syndrome and rheumatoid arthritis. Ann Rheum Dis52:806-81 1.
20.
Eguchi K., Matsuoka N., Ida H., Nakashima M., Sakai M., Sakito S., et al. (1992). Primary Sjogren's syndrome with antibodies to HTLV-1: Clinical and laboratory features. Ann Rheum Dis51:769-776.
21.
Falzon M., Isaacson PG (1991). The natural history of benign lymphoepithelial lesions of the salivary gland in which there is a monoclonal population of B cells. Am J Surg Pathol15:59-65.
22.
Fishleder A., Tubbs R., Hesse B., Levine H. (1987). Uniform detection of immunoglobulin gene rearrangement in benign lymphoepithelial lesions. N Engl J Med316:1118-1121.
23.
Fox PC (1985). Simplified biopsy techique for labial minor salivary glands. Plastic Reconstruct Surg75:592-593.
24.
Fox PC, Grisius M., Bermudez D., Sun D. (1995). IL-6 in primary Sjogren's syndrome and a human salivary cell line (abstract). Clin Rheumatol14(Suppl 1):44.
25.
Fox RI, Saito I. (1994). Sjogren's syndrome: immunologic and neuroendocrine mechanisms. In: Lacrimal gland, tear film, and dry eye syndromes. Sullivan DA, editor. New York: Plenum Press, pp. 609-621.
26.
Fox RI, Hugli TE, Lanier LL, Morgan EL, Howell F. (1985a). Salivary gland lymphocytes in primary Sjogren's syndrome lack lymphocyte subsets defined by leu-7 and leu-11 antigens. J Immunol135:207-214.
27.
Fox RI, Theofilopoulos AN, Altman A. (1985b). Production of interleukin 2 (IL 2) by salivary gland lymphocytes in Sjögren's syndrome. Detection of reactive cells by using antibody directed to synthetic peptides of IL 2. J Immunol135:3109-3115.
28.
Fox RI, Robinson CA, Curd JG, Kozin F., Howell FV (1986a). Sjogren's syndrome: Proposed criteria for classification. Arthritis Rheum29:577-585.
29.
Fox RI, Chen P., Carson DA, Fong S. ( 1986b). Expression of cross-reactive idiotype on rheumatoid factor in patients with Sjogren's syndrome. J Immunol136:477-483.
30.
Fox RI, Luppi M., Kang H., Pisa P. ( 1991). Reactivation of Epstein-Barr virus in Sjogren's syndrome. Springer Sem Immunopathol13:217-231.
31.
Fox RI, Luppi M., Pisa P., Kang H. ( 1992). Potential role of Epstein-Barr virus in Sjogren's syndrome and rheumatoid arthritis. J Rheumatol19(Suppl 32):18-24.
32.
Fox RI, Luppi M., Kang HHI, Ablshi D., Josephs S. (1993). Detection of high levels of human herpes virus-6 DNA in a lymphoma of a patient with Sjogren's syndrome (letter). J Rheumatol20:764-765.
33.
Fox RI, Kang H., Ando D., Abrams J., Pisa E. ( 1994). Cytokine mRNA expression in salivary gland biopsies of Sjogren's syndrome. J Immunol152:5532-5539.
34.
Freimark B., Fantozzi R., Bone R., Bordin G., Fox R. (1989). Detection of clonally expanded salivary gland lymphocytes in Sjogren's syndrome. Arthritis Rheum32:859-869.
35.
Garry R. (1994). New evidence for involvement of retroviruses in Sjogren's syndrome and other autoimmune diseases (editorial). Arthritis Rheum37:465-469.
36.
Garry RF, Fermin CD, Hart DJ, Alexander SS, Donehower LA, Luo-Zhang H. (1990). Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science250:1127-1129.
37.
Gleeson MJ, Cawson RA, Bennett MH (1986). Benign lymphoepithelial lesion: a less than benign disease. Clin Otolaryngol11:47-51.
38.
Godwin JT (1952). Benign lymphoepithelial lesion of the parotid gland (adenolymphoma, chronic inflammation, lymphoepithelioma, lymphocytic tumor, Mikulicz disease): Report of eleven cases. Cancer5:1089-1103.
39.
Gorgoulis V., Giatromanolaki A., Iliopoulos A., Kanavaros P., Aninos D., Ioakeimidis D., et al (1993). EGF and EGF-r immunoexpression in Sjogren's syndrome secondary to rheumatoid arthritis. Correlation with EBV expression? Clin Exp Rheumatol11:623-627.
40.
Haddad J., Deny P., Munz-Gotheil C., Ambrosini JC (1992). Lymphocytic sialoadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet8:321-323.
41.
Holm LE, Blomgren H., Lowhagen T. (1985). Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med312:601-604.
42.
Hyjek E., Smith WJ, Isaacson PG (1988). Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialoadenitis. Human Pathol19:766-776.
43.
Ichikawa Y., Shimizu H., Yoshida M., Takaya M., Arimori S. (1992). Accessory molecules expressed on the peripheral blood or synovial fluid T lymphocytes from patients with Sjogren's syndrome or rheumatoid arthritis. Clin Exp Rheum10:447-454.
Isenberg DA, Rowe D., Tookman A., Hopp A., Griffiths M., Paice E., et al. (1984). An immunohistological study of secondary Sjogren's syndrome. Ann Rheum Dis43:470-476.
48.
Jordan RCK, Pringle JH, Speight PM (1995a). High frequency of light chain restriction in labial gland biopsies of Sjogren's syndrome detected by in situ hybridization. J Pathol177:35-40.
49.
Jordan RCK, Diss TC, Lench J., Isaacson PG, Speight PM (1995b). Immunoglobulin gene rearrangements in lymphoplasmacytic infiltrates of labial salivary glands in Sjogren's syndrome: A possible predictor of lymphoma development. Oral Surg Oral Med Oral Pathol79:723-729.
50.
Jordan RCK, Odell EW, Speight PM (1996). B-cell monoclonality in salivary lymphoepithelial lesions. Oral Oncol Eur J Cancer32(B):38-44.
51.
Jorgensen JL, Esser U., de St Groth BF, Reay PA, Davis MM (1992). Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature355:224-230.
52.
Kapp A (1993). The role of cytokines in the psoriatic inflammation. J Derm Sci5:133-142.
53.
Karameris A., Gorgoulis V., Iliopoulos A., Frangia C., Kontomerkos T., loakeimidis D., et al. (1992). Detection of the Epstein-Barr viral genome by an in situ hybridization method in salivary gland biopsies from patients with secondary Sjogren's syndrome. Clin Exp Rheumatol10:327-332.
54.
Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R., Kimberly RP, Budman DR (1978). Increased risk of lymphoma in sicca syndrome. Ann Intern Med89:888-892.
55.
Katz J., Nagler R., Barak S., Livneh A., Baum B., Atkinson J., et al. (1994). Cytokines modulate interleukin-6 production by human salivary gland cell line. Cell Immunol159:211-219.
56.
Legras F., Martin T., Knapp A-M., Pasquali J-L. (1994). Infiltrating T cells from patients with primary Sjögren's syndrome express restricted or unrestricted T cell receptor Vβ regions depending on the stage of the disease. Eur J Immunol24:181-185.
57.
Lindahl G., Hedfors E., Klareskog L., Forsum U. (1985). Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjogren's syndrome. Clin Exp Immunol61:475-482.
58.
Maddison PJ (1993). Autoantibodies in Sjogren's syndrome: their origins and pathological consequences. In Autoimmune diseases. Isenberg DA, Horsfall AC, editors. Oxford: BIOS Scientific Publishers Ltd., pp. 89-98.
59.
Manthorpe R., Oxholm P., Prause JU, Schiodt M. (1986). The Copenhagen criteria for Sjogren's syndrome. Scand J Rheumatol (Suppl 61):19-21.
60.
Mariette X., Gozlan J., Clerc D., Bisson M., Morinet F. (1991). Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjogren's syndrome. Am J Med90:286-294.
61.
Mariette X., Zerbib M., Jaccard A., Schenmetzler C., Danon F. (1993a). Hepatitis-C virus and Sjogren's syndrome. Arthritis Rheum36:280-281.
62.
Mariette X., Agbalika F., Daniel M. Bisson M., Lagrange P., Brouet I., et al. (1993b). Detection of human T lymphotropic virus type I tax gene in salivary gland epithelium from two patients with Sjogren's syndrome. Arthritis Rheum36:1423-1428.
63.
Marrone A., Di Bisceglie AM, Fox PC (1995). Absence of hepatitis C viral infection among patients with primary Sjogren's syndrome (brief report). J Hepatol22:599.
64.
Marson P., Ostuni PA, Vicarioto M., Ongaro G., Gambari PF (1991). Anti-hepatitis C virus serology in primary Sjögren's syndrome: No evidence of cross-reactivity between rheumatoid factor and specific viral proteins. Clin Exp Rheumatol9:661-662.
65.
Matthews JB, Deacon EM, Kitas GD, Salmon M., Potts AJC, Hamburger J., et al. (1991). Primed and naive helper T cells in labial glands from patients with Sjogren's syndrome. Virch Arch A Pathol Anat419:191-197.
66.
Matthews JB, Deacon EM, Wilson C., Potts AJC, Hamburger J. (1993). Plasma cell populations in labial salivary glands from patients with and without Sjogren's syndrome. Histopathol23:399-407.
67.
Moutsopoulos HM, Steinberg AD, Fauci AS, Lanes HC, Papadopoulos NM (1983). High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome. J Immunol130:2663-2665
68.
Moutsopoulos HM, Costello R., Drosos AA, Mavridis AK, Papadopoulos NM (1985). Demonstration and identification of monoclonal proteins in the urine of patients with Sjogren's syndrome. Ann Rheum Dis44:109-112.
69.
Moutsopoulos HM, Tzioufas AG, Bai MK, Papadopoulos NM (1990). Association of serum IgM kappa monoclonicity in patients with Sjogren's syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glands. Ann Rheum Dis49:929-931.
70.
Offner H., Hashim GA, Vandenbark AA (1991). T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science251:430-432.
71.
Oosterveer MA, Markusse HM, Lennette ET, Zou JZ, Bolhuis RL, Gratama JW (1993). Characterization of Epstein-Barr virus strains in parotid gland saliva and peripheral blood of patients with primary Sjogren's syndrome and healthy EBV carriers. J Med Virol41:261-269.
72.
Oxholm P., Daniels TE, Bendtzen K. (1992). Cytokine expression in labial salivary glands from patients with primary Sjogren's syndrome. Autoimmunity12:185-191.
73.
Pavlidis NA, Drosos AA, Papdimitriou C., Talal N., Moutsopoulos HM (1992). Lymphoma in Sjogren's syndrome. Med Ped Oncol20:279-283.
74.
Pflugfelder SC, Crouse C., Pereira I., Atherton S. (1990). Amplification of Epstein-Barr virus genomic sequences in blood cells, lacrimal glands, and tears from primary Sjogren's syndrome patients. Ophthalmol97:976-084.
75.
Picker LJ (1994). Control of lymphocyte homing Curr Opin Immunol6:394-406.
76.
Pigott R., Power C. (1993). The adhesion molecule facts book. London: Academic Press.
77.
Rice GE, Munro JM, Bevilacqua MP (1990). Inducible cell adhesion molecule 110 (INCAM-110) is an inducible endothelial cell receptor for lymphocytes. I Exp Med171:1369-1374.
78.
Rowe D., Griffiths M., Stewart J., Novick D., Beverley PCL, Isenberg DA (1987) HLA class I and II, interferon, interleukin 2, and the interleukin 2 receptor expression on labial biopsy specimens from patients with Sjogren's syndrome. Ann Rheum Dis46:580-586.
79.
Saito I, Servenius B., Compton T., Fox RI (1989) Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. I Exp Med169:2191-2198.
80.
Saito I., Terauchi K., Shimuta M., Nishimura S., Yoshino K., Takeuchi T., et al. (1993). Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndrome. J Clin Lab Anal7:180-187.
81.
Santana V., Rose WR ( 1992). Neoplastic lymphoproliferation in autoimmune disease: An updated review. Clin Immunol Immunopathol63:205-213.
82.
Schmid U., Helbron D., Lennert K. (1982). Development of malignant lymphomas in myoepithelial sialadenitis (Sjogren's syndrome). Virch Arch A395:11-43.
83.
Shattles WG, Brookes SM, Venables PJW, Clark DA, Maini RN (1992). Expression of antigen reactive with a monoclonal antibody to HTLV-1 pl9 in salivary glands in Sjogren's syndrome. Clin Exp Immunol89:46-51.
84.
Shin SS, Sheibani K., Fishleder A., Ben-Ezra J., Bailey A., Koo CH, et al. (1991) Monocytoid B-cell lymphoma in patients with Sjogren's syndrome: A clinicopathologic study of 13 patients. Human Pathol22:422-430.
85.
Skopouli FN, Fox PC, Galanopoulou V., Atkinson JC, Jaffe ES, Moutsopoulos HM (1991). T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjogren's syndrome. J Rheumatol18:210-214.
86.
Speight PM, lordan R. (1993). The molecular pathology of Sjogren's syndrome. In: Autoimmune diseases. Isenberg DA, Horsfall AC, editors. Oxford: BIOS Scientific Publishers Ltd., pp. 25-38.
87.
Speight PM, Cruchley A., Williams DM (1990). Quantification of plasma cells in labial salivary glands: increased expression of IgM in Sjogren's syndrome. J Oral Pathol Med19:126-130.
88.
Speight PM, Jordan R., Colloby P., Nandha H., Pringle JH (1994). Early detection of lymphomas in Sjogren's syndrome by in-situ hybridization for kappa and lambda light chain mRNA in labial salivary glands. Oral Oncol Eur J Cancer30(B):244-247.
89.
St Clair EW, Angellilo JC, Singer KH (1992). Expression of cell-adhesion molecules in the salivary gland microenvironment of Sjogren's syndrome. Arthritis Rheum35:62-66.
90.
Strand V., Talal N. (1980). Advances in the diagnosis and concept of Sjogren's syndrome (autoimmune exocrinopathy). Bull Rheum Dis30:1046-1052.
91.
Sumida T., Yonaha F., Maeda T., Tanabe E., Koike T., Tomioka H., et al. (1992). T cell receptor repertoire of infiltrating T cells in lips of Sjogren's syndrome patients. J Clin Invest89:681-685.
92.
Sumida T., Yonaha F., Maeda T., Kita Y., Iwamoto I., Koike T., et al. (1994). Expression of sequences homologous to HTLV-1 tax gene in the labial salivary glands of lapanese patients with Sjogren's syndrome. Arthritis Rheum37:545-550.
93.
Talal N., Sokoloff L., Barth WF (1967). Extrasalivary lymphoid abnormalities in Sjogren's syndrome (reticulum-cell sarcoma, "pseudolymphoma", macroglobulinaemia). Am J Med43:50-65.
94.
Talal N., Asofsky R., Lightbody P. (1970). Immunoglobulin synthesis by salivary gland lymphoid cells in Sjogren's syndrome. J Clin Invest49:49-54.
95.
Talal N., Dauphinee M., Dang H., Alexander S., Hart D., Garry R. (1990). Detection of serum antibodies to retroviral proteins in patients with primary Sjogren's syndrome. Arthritis Rheum33:774-781.
96.
Tateishi M., Saito I., Yamamoto K., Miyasaka N. (1993). Spontaneous production of Epstein-Barr virus by B-lymphoblastoid cell lines obtained from patients with Sjogren's syndrome: Possible involvement of a novel strain of Epstein-Barr virus in disease pathogenesis. Arthritis Rheum36:827-835.
97.
Thornhill M., Wellicome SM, Hahiouz DL, Lanchbury JS, Kyan-Aung U., Haskard DO (1991). Tumour necrosis factor combines with 11-4 or interferon gamma to selectively enhance endothelial cell adhesiveness for T cells. J Immunol146:592-598.
98.
Tzioufas AG, Moutsopoulos HM, Talal N. (1987). Lymphoid malignancy and monoclonal proteins. In: Sjogren's syndrome: Clinical and immunological aspects. Talal N, Moutsopoulos HM, Kassan SS, editors. New York: Springer-Verlag, pp. 129-136.
99.
Urban JL, Kumar V., Kono DH, Gomez C., Horvath SJ, Clayton J., et al. (1988). Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell54:577-592.
100.
Venables PJ, Teo CG, Baboonian C., Griffin BE, Hughes RA (1989). Persistence of Epstein-Barr virus in salivary gland biopsies from healthy individuals and patients with Sjogren's syndrome. Clin Exp Immunol75:359-364.
101.
Vitali C., Sciuto M., Neri R., Greco F., Marridis AK, Tsioufas AG, et al. (1992). Anti-hepatitis C virus antibodies in primary Sjogren's syndrome: False-positive results are related to hypergammaglobulinaemia. Clin Exp Rheumatol10:103-104.
102.
Vitali C., Bombardieri S., Moutsopoulos HM, Balestrieri G., Bencivelli W., Bernstein RM, et al. (1993). Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum36:340-347.
103.
Walters MT, Stevenson FK, Herbert A., Cawley MID, Smith JL (1986). Urinary monoclonal free light chains in primary Sjogren's syndrome: an aid to the diagnosis of malignant lymphoma. Ann Rheum Dis45:210-219.
104.
Wilkinson LS, Edwards JCW, Poston R., Haskard DO (1993). Cell populations expressing VCAM-1 in normal and diseased synovium. Lab Invest68:82-88.
105.
Wolf H., Haus M., Wilmes E. (1984). Persistence of Epstein-Barr virus in the parotid gland. J Virol51:795-798.
106.
Wraith DC, Smilek DE (1992). A role for major histocompatibility complex-binding peptides in the immunotherapy of autoimmune disease. Springer Sem Immunopathol14:95-101.
107.
Wraith DC, McDevitt HD, Steinman L., Acha-Orbea H. (1989). T cell recognition as the target for immune intervention in autoimmune disease. Cell57:709-715.
108.
Wu AJ, Kurrasch RH, Katz J., Fox PC, Baum BJ, Atkinson JC (1994). Effect of tumor necrosis factor-a and interferon-γ on the growth of a human salivary cell line. J Cell Physiol161:217-226.
109.
Yamoaka K., Miyasaka N., Sato K., Okuda M., Nishioka K. (1989). B cell hyperresponsiveness in Sjogren's syndrome. Autoimmunity3:261-269.
110.
Yonaha F., Sumida T., Maeda T., Tomioka H., Koike T., Yoshida S. (1992). Restricted junctional usage of T cell receptor Vβ2 and Vβ13 genes, which are overrepresented on infiltrating T cells in the lips of patients with Sjogren's syndrome. Arthritis Rheum35:1362-1367.
111.
Zulman J., Jaffe R., Talal N. (1978). Evidence that the malignant lymphoma of Sjogren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med299:1215-1220.
